Cryopreserved embryo transfer is an independent risk factor for placenta accreta
- PMID: 25747133
- DOI: 10.1016/j.fertnstert.2015.01.021
Cryopreserved embryo transfer is an independent risk factor for placenta accreta
Abstract
Objective: To explore the association between cryopreserved embryo transfer (CET) and risk of placenta accreta among patients utilizing in vitro fertilization (IVF) and/or intracytoplasmic sperm injection (ICSI).
Design: Case-control study.
Setting: Academic medical center.
Patient(s): All patients using IVF and/or ICSI, with autologous or donor oocytes, undergoing fresh or cryopreserved transfer, who delivered a live-born fetus at ≥24 weeks of gestation at our center, from 2005 to 2011 (n = 1,571), were reviewed for placenta accreta at delivery.
Intervention(s): Cases of accreta (n = 50) were matched by age and prior cesarean section to controls (1:3) without accreta. The association between CET and accreta was modeled using conditional logistic regression, controlling a priori for age and placenta previa. Receiver operating characteristic curves were used to determine thresholds of endometrial thickness and peak serum E2 levels related to accreta.
Main outcome measure(s): Placenta accreta.
Result(s): Univariate predictors of accreta were non-Caucasian race (odds ratio [OR] 2.85, 95% confidence interval [CI] 1.25-6.47); uterine factor infertility (OR 5.80, 95% CI 2.49-13.50); prior abdominal or laparoscopic myomectomy (OR 7.24, 95% CI 1.92-27.28); and persistent or resolved placenta previa (OR 4.25, 95% CI 1.94-9.33). In multivariate analysis, we observed a significant association between CET and accreta (adjusted OR 3.20, 95% CI 1.14-9.02), which remained when analyses were restricted to cases of accreta with morbid complications (adjusted OR 3.87, 95% CI 1.08-13.81). Endometrial thickness and peak serum E2 level were each significantly lower in CET cycles and those with accreta.
Conclusion(s): Cryopreserved ET is a strong independent risk factor for accreta among patients using IVF and/or ICSI. A threshold endometrial thickness and a "safety window" of optimal peak E2 level are proposed for external validation.
Keywords: Adherent placenta; IVF; estradiol safety window; frozen embryo; trophoblast.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Pathologic maternal and neonatal outcomes associated with programmed embryo transfer.J Assist Reprod Genet. 2024 Apr;41(4):821-842. doi: 10.1007/s10815-024-03041-9. Epub 2024 Mar 27. J Assist Reprod Genet. 2024. PMID: 38536594 Review.
-
Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.Fertil Steril. 2015 May;103(5):1194-1201.e2. doi: 10.1016/j.fertnstert.2015.02.020. Epub 2015 Mar 23. Fertil Steril. 2015. PMID: 25813280
-
Endometrial thickness is associated with incidence of small-for-gestational-age infants in fresh in vitro fertilization-intracytoplasmic sperm injection and embryo transfer cycles.Fertil Steril. 2020 Apr;113(4):745-752. doi: 10.1016/j.fertnstert.2019.12.014. Epub 2020 Mar 5. Fertil Steril. 2020. PMID: 32147172
-
Outcomes of singleton births after blastocyst versus nonblastocyst transfer in assisted reproductive technology.Fertil Steril. 2012 Mar;97(3):579-84. doi: 10.1016/j.fertnstert.2011.12.032. Epub 2012 Jan 26. Fertil Steril. 2012. PMID: 22281036
-
Pregnancy-related complications and perinatal outcomes resulting from transfer of cryopreserved versus fresh embryos in vitro fertilization: a meta-analysis.Fertil Steril. 2018 Feb;109(2):330-342.e9. doi: 10.1016/j.fertnstert.2017.10.019. Epub 2018 Jan 11. Fertil Steril. 2018. PMID: 29331236 Review.
Cited by
-
Assisted reproductive technology-associated risk factors for placenta accreta spectrum after vaginal delivery.Sci Rep. 2024 Mar 29;14(1):7454. doi: 10.1038/s41598-024-57988-x. Sci Rep. 2024. PMID: 38548810 Free PMC article.
-
Pathologic maternal and neonatal outcomes associated with programmed embryo transfer: potential etiologies and strategies for prevention.J Assist Reprod Genet. 2024 Apr;41(4):843-859. doi: 10.1007/s10815-024-03042-8. Epub 2024 Mar 27. J Assist Reprod Genet. 2024. PMID: 38536596 Review.
-
Pathologic maternal and neonatal outcomes associated with programmed embryo transfer.J Assist Reprod Genet. 2024 Apr;41(4):821-842. doi: 10.1007/s10815-024-03041-9. Epub 2024 Mar 27. J Assist Reprod Genet. 2024. PMID: 38536594 Review.
-
Risk factors for postpartum haemorrhage in women with histologically verified placenta accreta spectrum disorders: a retrospective single-centre cross-sectional study.BMC Pregnancy Childbirth. 2023 Nov 11;23(1):786. doi: 10.1186/s12884-023-06103-5. BMC Pregnancy Childbirth. 2023. PMID: 37951863 Free PMC article.
-
Increased risk of postpartum hemorrhage in cesarean delivery.J Anesth. 2024 Feb;38(1):145-146. doi: 10.1007/s00540-023-03279-0. Epub 2023 Oct 31. J Anesth. 2024. PMID: 37907690 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources